Stomski N J, Morrison P, Meehan T
School of Health Professions, Murdoch University, Murdoch, WA, Australia.
School of Medicine, University of Queensland, Richlands, QLD, Australia.
J Psychiatr Ment Health Nurs. 2016 Aug;23(6-7):369-77. doi: 10.1111/jpm.12314. Epub 2016 Jun 28.
WHAT IS KNOWN ON THE SUBJECT?: The only previous quantitative study that examined nurses' use of assessment tools to identify antipsychotic medication side effects found that about 25% of mental health nurses were using assessment tools. No previous studies have examined factors that influence the manner in which mental health nurses assess antipsychotic medication side effects. WHAT THIS PAPER ADDS TO EXISTING KNOWLEDGE?: One-third of the respondents were not aware of any antipsychotic medication side-effect assessment tool, and only one-quarter were currently using an assessment tool. 'Service responsibility' was significantly associated with ongoing use of antipsychotic medication assessment tools, indicating that respondents with more positive attitudes to their service were more likely to continue using antipsychotic medication assessment tools. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: The low level of awareness and use of antipsychotic medication side-effect assessment tools indicates that nursing educational institutions should incorporate more detail about these tools in course content, and emphasize in particular the benefits that result from the use of these tools in clinical practice. Service processes contributed significantly to the use of antipsychotic medication assessment tools, which indicates that managers need to foster workplace cultures that promote routine use of these tools.
Introduction Limited evidence suggests that only a minority of mental health nurses regularly use standardized assessment tools to assess antipsychotic medication side effects, but the factors that contribute to the non-routine use of these tools remain unknown. Aim To examine Australian mental health nurses' awareness of, and attitudes towards, side-effect assessment tools, and also identify factors the influence the use of these tools. Methods A cross-sectional survey was undertaken through distributing an online questionnaire via email to members of the Australian College of Mental Health Nurses. Completed questionnaires were received from 171 respondents. Linear regression was used to examine the relationship between the 'service responsibility' and 'personal confidence' scale scores, and awareness, previous use and ongoing use of antipsychotic medication assessment tools. Results Only one-quarter of the respondents (26.5%) were currently using an assessment tool. 'Service responsibility' was significantly associated with ongoing use of antipsychotic medication assessment tools (Β = 3.26; 95% CI 0.83-5.69). 'Personal confidence' did not influence the ongoing use of assessment tools (Β = -0.05; 95% CI -1.06-1.50). Implications for clinical practice Stakeholders can incorporate 'service responsibility' processes to foster increased use of assessment tools, which may enhance the identification antipsychotic medication side effects and improve the quality of care for service users.
关于该主题已知的信息有哪些？：之前唯一一项调查护士使用评估工具来识别抗精神病药物副作用情况的定量研究发现，约25%的精神科护士在使用评估工具。此前没有研究考察过影响精神科护士评估抗精神病药物副作用方式的因素。本文对现有知识的补充是什么？：三分之一的受访者不知道任何抗精神病药物副作用评估工具，只有四分之一的人目前正在使用评估工具。“服务责任感”与持续使用抗精神病药物评估工具显著相关，这表明对其服务态度更积极的受访者更有可能继续使用抗精神病药物评估工具。对实践有何启示？：抗精神病药物副作用评估工具的知晓度和使用率较低，这表明护理教育机构应在课程内容中纳入更多关于这些工具的详细信息，并特别强调在临床实践中使用这些工具所带来的益处。服务流程对抗精神病药物评估工具的使用有显著贡献，这表明管理人员需要营造促进常规使用这些工具的工作场所文化。
引言 有限的证据表明，只有少数精神科护士定期使用标准化评估工具来评估抗精神病药物的副作用，但导致这些工具未被常规使用的因素尚不清楚。目的 考察澳大利亚精神科护士对抗精神病药物副作用评估工具的知晓度和态度，并确定影响这些工具使用的因素。方法 通过电子邮件向澳大利亚精神科护士学院的成员分发在线问卷进行横断面调查。共收到171名受访者填写的问卷。采用线性回归分析“服务责任感”和“个人信心”量表得分与抗精神病药物评估工具的知晓度、既往使用情况和持续使用情况之间的关系。结果 只有四分之一的受访者（26.5%）目前正在使用评估工具。“服务责任感”与持续使用抗精神病药物评估工具显著相关（β = 3.26；95%可信区间0.83 - 5.69）。“个人信心”并未影响评估工具的持续使用（β = -0.05；95%可信区间 -1.06 - 1.50）。对临床实践的启示 利益相关者可以纳入“服务责任感”流程，以促进评估工具的更多使用，这可能会加强对抗精神病药物副作用的识别，并提高服务使用者的护理质量。
